TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2
ASSAY and Drug Development Technologies · 2023
DOI: 10.1089/adt.2022.099 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2023. Verfasst von Ying Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, No. 903 Hospital of PLA Joint Logistic Support Force, Xi Hu Affiliated Hospital of Hangzhou Medical College, Hangzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, No. 903 Hospital of PLA Joint Logistic Support Force, Xi Hu Affiliated Hospital of Hangzhou Medical College, Hangzhou, China.
- Department of Gastroenterology, Hangzhou Xixi Hospital, Hangzhou, China.
ORCID-Profile: Bo Wu
Zitieren
APA
Liu, Y., Chen, M., & Wu, B. (2023). TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2022.099
Vancouver
Liu Y, Chen M, Wu B. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2. ASSAY and Drug Development Technologies. 2023. doi:10.1089/adt.2022.099
BibTeX
@article{Liu2023,
author = {Liu, Ying and Chen, Minhan and Wu, Bo},
title = {TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2},
journal = {ASSAY and Drug Development Technologies},
year = {2023},
doi = {10.1089/adt.2022.099}
}
EUVIMED